Citation
Abstract
Non-invasive prenatal testing was first discovered in 1988; it was primarily thought to be able to detect common aneuploidies, such as Patau syndrome (T13), Edward Syndrome (T18), and Down syndrome (T21). It comprises a simple technique involving the analysis of cell-free foetal DNA (cffDNA) obtained through maternal serum, using advances in next-generation sequencing. NIPT has shown promise as a simple and low-risk screening test, leading various governments and private organizations worldwide to dedicate significant resources towards its integration into national healthcare initiatives as well as the formation of consortia and research studies aimed at standardizing its implementation. This article aims to review the reliability of NIPT while discussing the current challenges prevalent among different communities worldwide.
Download File
Full text not available from this repository.
Official URL or Download Paper: https://www.mdpi.com/2075-4418/13/15/2570
|
Additional Metadata
| Item Type: | Article |
|---|---|
| Divisions: | Faculty of Medicine and Health Science |
| DOI Number: | https://doi.org/10.3390/diagnostics13152570 |
| Publisher: | Multidisciplinary Digital Publishing Institute |
| Keywords: | NIPT; Prenatal testing; Pregnancy; Aneuploidy; Risomy; Next-generation sequencing; Cell-free foetal DNA (cffDNA); Obstetrics |
| Depositing User: | Ms. Zaimah Saiful Yazan |
| Date Deposited: | 04 Sep 2024 04:17 |
| Last Modified: | 04 Sep 2024 04:17 |
| Altmetrics: | http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.3390/diagnostics13152570 |
| URI: | http://psasir.upm.edu.my/id/eprint/110169 |
| Statistic Details: | View Download Statistic |
Actions (login required)
 |
View Item |